Trial Profile
Apremilast Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2023
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions
- 22 May 2023 Planned End Date changed from 1 Jul 2024 to 1 Jul 2025.
- 22 May 2023 Planned primary completion date changed from 1 Feb 2022 to 1 Apr 2024.
- 22 May 2023 Status changed from recruiting to active, no longer recruiting.